AMBER MAISON: Open Payments
NPI 1962986349 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 68 payments from 18 companies in 2025. Trend: 2023 $357 · 2024 $1,102 · 2025 $1,607
Food & beverage: $1,507Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $446 |
| Janssen Biotech, Inc. | 14 | $369 |
| Arcutis Biotherapeutics, Inc. | 2 | $136 |
| GENZYME CORPORATION | 3 | $116 |
| Amgen Inc. | 2 | $114 |
| Hill Dermaceuticals, Inc. | 2 | $52 |
| Galderma Laboratories, L.P. | 1 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Zoryve, Tolak, NEMLUVIO, CIBINQO, BLU-U.
Industry payments across AZ — which companies pay providers there.
